The efficacy of influenza vaccine for healthy children - a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality

被引:91
作者
Manzoli, Lamberto
Schioppa, Francesco
Boccia, Antonio
Villari, Paolo
机构
[1] Univ G DAnnunzio, Sez Epidemiol & San Pubbl, Dept Med & Aging Sci, I-66013 Chieti, Italy
[2] Univ Roma La Sapienza, Dept Expt Med, Sect Clin Med & Publ Hlth, I-00185 Rome, Italy
关键词
influenza vaccine; healthy children; efficacy; pediatrics; meta-analysis; ACUTE OTITIS-MEDIA; METHODOLOGICAL QUALITY; YOUNG-CHILDREN; VIRUS-VACCINE; LIVE; TRIVALENT; PROTECTION; TRIALS; BIAS; SCHOOLCHILDREN;
D O I
10.1097/01.inf.0000253053.01151.bd
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Two systematic reviews evaluating influenza vaccine efficacy in healthy children have recently been published. Although quantitative summary estimates were similar, authors' conclusions were quite contrasting. We carried out another meta-analysis reevaluating study inclusion criteria and using metaregression techniques in addition to sensitivity and subgroups analyses to evaluate potential sources of heterogeneity of efficacy estimates, including methodologic quality of studies. Methods: Only randomized clinical studies assessing the efficacy of influenza vaccine in healthy children/adolescents (age <= 18 years) for preventing naturally occurring influenza and/or acute otitis media cases were included. Summary estimates of effect were obtained using a random effects model. The methodologic quality of each study was assessed using 3 systems: Chalmers scale, Jadad scale and Schulz components (randomization, allocation concealment and double-blinding). Results: The overall vaccination efficacy was 36% (95% confidence interval: 31-40%) against clinically diagnosed illnesses (evaluated by 19 randomized clinical studies for a total of 247,517 children); 67% (51-78%) against laboratory-confirmed cases (18 trials, n = 8574); and 51% (21-70%) against acute otitis media (11 trials, n = 11,349). Significant sources of between-study heterogeneity were participants' age and study quality both directly correlated with the efficacy. When the analysis was performed excluding USSR studies, the overall efficacy of the vaccine in preventing clinical cases substantially increased (from 36% to 61%). Conclusions: These findings may indicate that the vaccine efficacy might be greater than the overall estimates. Although no safety and cost considerations are addressed in this analysis, the present findings support vaccination as a possible option for the prevention of influenza in healthy children and adolescents.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 51 条
[1]   STUDY OF LIVE RECOMBINANT COLD-ADAPTED INFLUENZA BIVALENT VACCINE OF TYPE-A FOR USE IN CHILDREN - AN EPIDEMIOLOGIC CONTROL TRIAL [J].
ALEXANDROVA, GI ;
BUDILOVSKY, GN ;
KOVAL, TA ;
POLEZHAEV, FI ;
GARMASHOVA, LM ;
GHENDON, YZ ;
ROMANOVA, YR ;
SMORODINTSEV, AA .
VACCINE, 1986, 4 (02) :114-118
[2]  
[Anonymous], WKLY EPIDEMIOL REC
[3]  
[Anonymous], SEMIN PEDIAT INFECT
[4]   OPERATING CHARACTERISTICS OF A BANK CORRELATION TEST FOR PUBLICATION BIAS [J].
BEGG, CB ;
MAZUMDAR, M .
BIOMETRICS, 1994, 50 (04) :1088-1101
[5]   Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine [J].
Belshe, RB ;
Gruber, WC ;
Mendelman, PM ;
Cho, I ;
Reisinger, K ;
Block, SL ;
Wittes, J ;
Iacuzio, D ;
Piedra, P ;
Treanor, J ;
King, J ;
Kotloff, K ;
Bernstein, DI ;
Hayden, FG ;
Zangwill, K ;
Yan, LH ;
Wolff, M .
JOURNAL OF PEDIATRICS, 2000, 136 (02) :168-175
[6]   The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children [J].
Belshe, RB ;
Mendelman, PM ;
Treanor, J ;
King, J ;
Gruber, WC ;
Piedra, P ;
Bernstein, DI ;
Hayden, FG ;
Kotloff, K ;
Zangwill, K ;
Iacuzio, D ;
Wolff, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1405-1412
[7]   EVALUATION OF A NEURAMINIDASE-SPECIFIC INFLUENZA-A VIRUS-VACCINE IN CHILDREN - ANTIBODY-RESPONSES AND EFFECTS ON 2 SUCCESSIVE OUTBREAKS OF NATURAL INFECTION [J].
BEUTNER, KR ;
CHOW, T ;
RUBI, E ;
STRUSSENBERG, J ;
CLEMENT, J ;
OGRA, PL .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (06) :844-850
[8]   A METHOD FOR ASSESSING THE QUALITY OF A RANDOMIZED CONTROL TRIAL [J].
CHALMERS, TC ;
SMITH, H ;
BLACKBURN, B ;
SILVERMAN, B ;
SCHROEDER, B ;
REITMAN, D ;
AMBROZ, A .
CONTROLLED CLINICAL TRIALS, 1981, 2 (01) :31-49
[9]   INFLUENZA-A VACCINE DECREASES THE INCIDENCE OF OTITIS-MEDIA IN 6- TO 30-MONTH-OLD CHILDREN IN DAY-CARE [J].
CLEMENTS, DA ;
LANGDON, L ;
BLAND, C ;
WALTER, E .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1995, 149 (10) :1113-1117
[10]   COMPARISON OF HETEROTYPIC PROTECTION AGAINST INFLUENZA A/TAIWAN/86 (H1N1) BY ATTENUATED AND INACTIVATED VACCINES TO A/CHILE/83-LIKE VIRUSES [J].
CLOVER, RD ;
CRAWFORD, S ;
GLEZEN, WP ;
TABER, LH ;
MATSON, CC ;
COUCH, RB .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) :300-304